|
EXOC6B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.84440000000108E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47989999998988E-06 |
| Normal-vs-Stage2 |
1.589600E-01 |
| Normal-vs-Stage3 |
1.000000E-01 |
| Normal-vs-Stage4 |
1.240180E-03 |
| Stage1-vs-Stage2 |
2.231600E-01 |
| Stage1-vs-Stage3 |
1.994820E-01 |
| Stage1-vs-Stage4 |
6.141200E-01 |
| Stage2-vs-Stage3 |
9.534600E-01 |
| Stage2-vs-Stage4 |
2.736000E-01 |
| Stage3-vs-Stage4 |
2.910400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.772960E-04 |
| Normal-vs-AfricanAmerican |
1.971470E-04 |
| Normal-vs-Asian |
4.396200E-03 |
| Caucasian-vs-AfricanAmerican |
5.104200E-01 |
| Caucasian-vs-Asian |
6.170400E-01 |
| AfricanAmerican-vs-Asian |
7.051400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.29270000551685E-08 |
| Normal-vs-Female |
7.499000E-01 |
| Male-vs-Female |
4.10530000000131E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.296750E-03 |
| Normal-vs-Extreme_Weight |
5.03550001695885E-09 |
| Normal-vs-Obese |
6.255900E-02 |
| Normal-vs-Extreme_Obese |
2.083700E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.673190E-01 |
| Normal_Weight-vs-Obese |
2.025600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.603800E-01 |
| Extreme_Weight-vs-Obese |
2.697500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.745200E-01 |
| Obese-vs-Extreme_Obese |
3.082600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.670600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.600810E-03 |
| Normal-vs-Age(61-80Yrs) |
4.80259999990906E-07 |
| Normal-vs-Age(81-100Yrs) |
3.08569999996067E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.699200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.580240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.404200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.265700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.024220E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.245240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.22119999457615E-08 |
| Normal-VS-Type2 PRCC |
1.019070E-03 |
| Normal-VS-KIRP CIMP |
4.130800E-01 |
| Normal-VS-Unclassified PRCC |
8.452000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.080230E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.109600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.238500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.127760E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.569700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.303800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.455700E-02 |
| Normal-vs-N1 |
3.192200E-01 |
| Normal-vs-N2 |
4.687200E-01 |
| N0-vs-N1 |
4.533200E-01 |
| N0-vs-N2 |
8.834400E-01 |
| N1-vs-N2 |
8.308400E-01 |
|
|
